Should I Buy RKDA? RKDA 2026 Analysis

Should You Buy Arcadia Biosciences Inc (RKDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

2.100

1 Day change

-3.67%

52 Week Range

6.710

Analysis Updated At

2026/01/26

Arcadia Biosciences Inc (RKDA) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, no positive trading or news catalysts, and bearish technical indicators. Additionally, there are no proprietary trading signals or significant institutional or insider activity to suggest a strong upside potential.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 37.741, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 2.655 and 2.794, while support levels are at 2.204 and 2.065. Overall, the technical indicators suggest a bearish trend.

Options Data

Positive Catalysts

NULL identified. No recent news, institutional activity, or insider trading trends to support a positive outlook.

Neutral/Negative Catalysts

Weak financial performance in Q3 2025, with revenue down 15.29% YoY, net income down 153.10% YoY, and EPS down 152.54% YoY. Gross margin also dropped by 25.14%. Additionally, the stock has a projected negative trend (-4.8% in the next week, -13.77% in the next month).

Financial Performance

In Q3 2025, Arcadia Biosciences reported a revenue decline of 15.29% YoY to $1,302,000. Net income dropped significantly by 153.10% YoY to $856,000, and EPS fell by 152.54% YoY to 0.62. Gross margin decreased by 25.14% to 32.1%. Overall, the financial performance indicates significant challenges for the company.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available for RKDA.

Analyst Rating

Wall Street analysts forecast RKDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKDA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold